National Center for Advancing Translational Sciences; Notice of Closed Meetings, 52000-52001 [2022-18216]
Download as PDF
<![CDATA[
52000
Federal Register / Vol. 87, No. 163 / Wednesday, August 24, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; T32/T35
Review Jan 2023 Council.
Date: October 13, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Anita H. Undale, Ph.D.,
MD, Scientific Review Branch, National
Institute on Aging, Gateway Building, Suite
2W200, 7201 Wisconsin Avenue, Bethesda,
MD 20892, (301) 827–7428, anita.undale@
nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nia.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 18, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–18193 Filed 8–23–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jspears on DSK121TN23PROD with NOTICES
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Center for Scientific
Review Advisory Council.
VerDate Sep<11>2014
19:09 Aug 23, 2022
Jkt 256001
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend in person as well as those who
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
register at (https://public.csr.nih.gov/
AboutCSR/Organization/
CSRAdvisoryCouncil/Registration) in
advance of the meeting so that the
meeting organizers can plan
accordingly.
The meeting will be videocast and can
be accessed from the NIH Videocasting
website (https://videocast.nih.gov/
watch=45767).
Name of Committee: Center for Scientific
Review Advisory Council.
Date: September 19, 2022.
Open: 10 a.m. to 4 p.m.
Agenda: Provide advice to the Director,
Center for Scientific Review (CSR), on
matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: National Institutes of Health, 6701
Rockledge Drive, Conference Rooms 260 C,
D, E and F, Bethesda, MD 20892.
Contact Person: Bruce Reed, Ph.D., Deputy
Director, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 594–9159,
reedbr@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Additional Health and Safety Guidance:
Before attending a meeting at an NIH facility,
it is important that visitors review the NIH
COVID–19 Safety Plan at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/Pages/default.aspx and the NIH
testing and assessment web page at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/
visitor-testing-requirement.aspx for
information about requirements and
procedures for entering NIH facilities,
especially when COVID–19 community
levels are medium or high. In addition, the
Safer Federal Workforce website has FAQs
for visitors at https://
www.saferfederalworkforce.gov/faq/visitors/.
Please note that if an individual has a
COVID–19 diagnosis within 10 days of the
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
meeting, that person must attend virtually.
(For more information please read NIH’s
Requirements for Persons after Exposure at
https://ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVID-assessmenttesting/Pages/persons-after-exposure.aspx
and What Happens When Someone Tests
Positive at https://ors.od.nih.gov/sr/dohs/
safety/NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/test-positive.aspx.)
Anyone from the public can attend the open
portion of the meeting virtually via the NIH
Videocasting website (https://
videocast.nih.gov). Please continue checking
these websites, in addition to the committee
website listed below, for the most up-to-date
guidance as the meeting date approaches.
Information is also available on the
Institute’s/Center’s home page: https://
public.csr.nih.gov/AboutCSR/Organization/
CSRAdvisoryCouncil, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 19, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–18262 Filed 8–23–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Rare Disease Review.
Date: September 16, 2022.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
E:\FR\FM\24AUN1.SGM
24AUN1
52001
Federal Register / Vol. 87, No. 163 / Wednesday, August 24, 2022 / Notices
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jing Chen, Ph.D., Scientific
Review Officer, Office of Scientific Review,
National Center for Advancing Translational
Sciences, National Institutes of Health, 6701
Democracy Boulevard, Room 1037, Bethesda,
MD 20892, (301) 827–3268, chenjing@
mail.nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CCIA Review Meeting.
Date: September 20, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892, (301) 412–9752,
lourdes.ponce@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 18, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–18216 Filed 8–23–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Advisory Committee for Women’s
Services (ACWS); Notice of Meeting
jspears on DSK121TN23PROD with NOTICES
Pursuant to Public Law 92–463,
notice is hereby given of a meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Advisory Committee for Women’s
Services (ACWS) on September 6, 2022.
This notice may publish under the 15
days due to agency’s unforeseen
exceptional scheduling conflict.
The meeting will include discussions
on assessing SAMHSA’s current
strategies, including the mental health
and substance use needs of the women
and girls population. Additionally, the
ACWS will be addressing priorities
regarding the impact of COVID–19 on
the behavioral health needs of women
and children and directions around
behavioral health services and access for
women and children.
The meeting is open to the public and
will be held virtually. Interested persons
may present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions should be forwarded to the
contact person by September 1, 2022.
Oral presentations from the public will
be scheduled at the conclusion of the
meeting. Individuals interested in
making oral presentations are
encouraged to notify the contact person
on or before September 1, 2022. Up to
five minutes will be allotted for each
presentation.
The meeting may be accessed via
telephone or web meeting. To obtain the
call-in number and access code, submit
written or brief oral comments, or
request special accommodations for
persons with disabilities, please register
on-line at: https://snacregister.
samhsa.gov or communicate with
SAMHSA’s Designated Federal Officer,
Ms. Valerie Kolick.
Substantive meeting information and
a roster of ACWS members may be
obtained either by accessing the
SAMHSA Committees’ Web https://
www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting Ms.
Kolick.
Committee Name: Substance Abuse
and Mental Health Services
Administration Advisory Committee for
Women’s Services (ACWS).
Date/Time/Type: Tuesday, September
6, 2022, from: 1:00 p.m. to 4:30p.m. EDT
(OPEN).
Place: SAMHSA, 5600 Fishers Lane,
Rockville, MD 20857 (Virtual).
Contact: Valerie Kolick, Designated
Federal Officer, SAMHSA’s Advisory
Committee for Women’s Services, 5600
Fishers Lane, Rockville, MD 20857,
Telephone: (240) 276–1738, Email:
Valerie.kolick@samhsa.hhs.gov.
Dated: August 19, 2022.
Carlos Castillo,
Capt, USPHS, Committee Management
Officer, Substance Abuse and Mental Health,
Services Administration.
[FR Doc. 2022–18236 Filed 8–23–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Customs and Border Protection
Notice of Revocation of Customs
Brokers’ Licenses
U.S. Customs and Border
Protection, Department of Homeland
Security.
AGENCY:
Revocation of customs brokers’
licenses.
ACTION:
This document provides
notice of the revocation by operation of
law of customs brokers’ licenses.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Melba Hubbard, Branch Chief, Broker
Management, Office of Trade, (202)
325–6986, melba.hubbard@cbp.dhs.gov.
This
document provides notice that,
pursuant to section 641 of the Tariff Act
of 1930, as amended (19 U.S.C. 1641),
and section 111.30(d) of title 19 of the
Code of Federal Regulations (19 CFR
111.30(d)), the following customs
brokers’ licenses were revoked by
operation of law, without prejudice, for
failure to file a triennial status report. A
list of revoked customs brokers’ licenses
appears below with both the port, which
issued the licenses, and the brokers’
names within the port of issuance
whose licenses were revoked, set forth
alphabetically.
SUPPLEMENTARY INFORMATION:
Last name/company name
First name
Johnston ................................................................
Klein ......................................................................
Mader ....................................................................
Allardice .................................................................
American Global Logistics ....................................
Bell ........................................................................
Blanc .....................................................................
Blanks ....................................................................
Boyd ......................................................................
Broyhill ...................................................................
CDS Global Logistics—One, LLC .........................
Connerly ................................................................
Egan ......................................................................
Kathy M ................................................................
Brenda ..................................................................
Mary L ..................................................................
Tracy Tumlin .........................................................
...............................................................................
Mark E ..................................................................
Evelyne .................................................................
Vincent Elliot .........................................................
Kathryn T ..............................................................
Eric .......................................................................
...............................................................................
Lori ........................................................................
Dennis Michael .....................................................
VerDate Sep<11>2014
19:09 Aug 23, 2022
Jkt 256001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
License
E:\FR\FM\24AUN1.SGM
20453
16428
14274
28429
32153
12539
30706
14816
13387
30594
15473
16853
11857
24AUN1
Port name
Anchorage.
Anchorage.
Anchorage.
Atlanta.
Atlanta.
Atlanta.
Atlanta.
Atlanta.
Atlanta.
Atlanta.
Atlanta.
Atlanta.
Atlanta.
]]>Agencies
[Federal Register Volume 87, Number 163 (Wednesday, August 24, 2022)]
[Notices]
[Pages 52000-52001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18216]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; Rare Disease Review.
Date: September 16, 2022.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of
[[Page 52001]]
Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jing Chen, Ph.D., Scientific Review Officer,
Office of Scientific Review, National Center for Advancing
Translational Sciences, National Institutes of Health, 6701
Democracy Boulevard, Room 1037, Bethesda, MD 20892, (301) 827-3268,
[email protected].
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; CCIA Review Meeting.
Date: September 20, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Room 1037,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences, National Institutes of Health, 6701
Democracy Boulevard, Room 1037, Bethesda, MD 20892, (301) 412-9752,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: August 18, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-18216 Filed 8-23-22; 8:45 am]
BILLING CODE 4140-01-P
